Evidence map›Paper›PMID 39951218›Full record

ArticleLasers in medical science2025

Efficacy and prognostic factors for successful treatment of port-wine stains by 577-nm yellow laser: a cohort study on 42 patients.

Essamelden M Mohamed, Hazem L Abdel-Aleem, Mofreh Mansour, Mahmoud A Rageh

Abstract read
In one paragraph

Article in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Essamelden M MohamedDepartment of Dermatology, Faculty of Medicine, Al-Azhar University, Assiut, Egypt.
Hazem L Abdel-AleemDepartment of Dermatology, Faculty of Medicine, Al-Azhar University, Assiut, Egypt.
Mofreh MansourDepartment of Dermatology, Faculty of Medicine for Girls, Al-Azhar University, Damietta, Egypt.
Mahmoud A RagehDepartment of Dermatology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt. dr.mahmoudrageh@azhar.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A port-wine stain (PWS) is a congenital capillary abnormality with an incidence of 0.3-0.5%. Although several other types of lasers have been used to treat PWSs, few studies have focused on the factors that affect the outcome of 577-nm yellow lasers. We aimed to assess the efficacy and prognostic factors affecting the PWS treatment by 577-nm yellow laser. This study was carried out on 42 patients with PWS. Each patient received 6-10 treatment sessions with a 577-nm yellow laser at 4-week intervals. Treatment efficacy was considered adequate when improvement of ≥ 80% of the lesion occurred. After treatment, marked improvement occurred in 7 (16.7%) patients, moderate improvement in 17 (40.5%) patients, mild improvement in 10 (23.8%) and 8 (19%) patients showed poor improvement. There was a significant association between improvement and gender of the patients and site of lesion (p = 0.028, p = 0.001, respectively). However, linear regression analysis showed that the site of the lesion can significantly predict the improvement (p < 0.001), while other baseline characteristics were not associated and cannot act as predictors for improvement. Yellow laser is a successful therapy choice for PWS, with a statistically significant improvement and minimal adverse effects. No significant association was found between improvement following laser therapy and baseline parameters, except for the location of PWS.

Indexed as

Low-Level Light TherapyPort-Wine StainAdolescentAdultChildChild, PreschoolCohort StudiesFemaleHumansMaleMiddle AgedPrognosisTreatment OutcomeYoung AdultBirth marksPort-wine stainVascular laserYellow laser

Identifiers

PMID39951218
PMCPMC11828787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.